Rosetta Biosoftware and GeneGo to Offer Interoperability between the Rosetta Resolver(R) System and MetaCore(TM)

From: CCNMatthews Newswire | Date: July 18, 2005 | Copyright information

SEATTLE & ST. JOSEPH, Mich.--(CCNMatthews - Jul 18, 2005) -

Rosetta Biosoftware and GeneGo, Inc. today announced a collaboration to establish interoperability between Rosetta Biosoftware's Resolver system and GeneGo's MetaCore system. Researchers will be able to easily exchange data between the MetaCore and Resolver systems to leverage both systems' ability to analyze gene expression data and perform sophisticated pathway analysis.

The Rosetta Resolver system is a versatile and ...

Related newspaper, magazine, and journal articles from HighBeam Research

FDA Licenses the Rosetta Resolver(R) System for Use in the Center for Drug Evaluation and Research
CCNMatthews Newswire ; SEATTLECCNMatthews - Aug 24, 2005) - Rosetta Biosoftware (NYSE:MRK) today announced that the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) will evaluate the Rosetta Resolver system for gene expression data management and analysis. CDER will use the Rosetta
Iconix Pharmaceuticals, Inc. and Rosetta Biosoftware Announce Collaboration
CCNMatthews Newswire ; SEATTLE & MOUNTAIN VIEW, CalifCCNMatthews - Jun 20, 2005) - Rosetta Biosoftware and Iconix Pharmaceuticals, Inc. today announced a collaboration to establish interoperability between Rosetta Biosoftware's Resolver(R) system and Iconix Pharmaceutical's DrugMatrix(R) Informatics system. Researchers
Rosetta Biosoftware and GeneGo to Offer Interoperability between the Rosetta Resolver(R) System and MetaCore(TM)
CCNMatthews Newswire ; SEATTLE & ST. JOSEPH, MichCCNMatthews - Jul 18, 2005) - Rosetta Biosoftware and GeneGo, Inc. today announced a collaboration to establish interoperability between Rosetta Biosoftware's Resolver system and GeneGo's MetaCore system. Researchers will be able to easily exchange data between the
Rosetta Biosoftware Licenses the Rosetta Resolver Gene Expression Analysis System to the Functional Genomics Center Zurich
CCNMatthews Newswire ; SEATTLE and ZURICH, SwitzerlandCCNMatthews - Nov 21, 2005) - Rosetta Biosoftware announced today that the Functional Genomics Center of Zurich, Switzerland (FGCZ) licensed the Rosetta Resolver system. The FGCZ will use the Resolver system to analyze and store cross-platform microarray data
Rosetta Biosoftware and Ingenuity Systems to Offer Interoperability between the Rosetta Resolver System and the Ingenuity Pathways Analysis System
CCNMatthews Newswire ; SEATTLE & REDWOOD CITY, CalifCCNMatthews - Jan 25, 2006) - Rosetta Biosoftware and Ingenuity Systems today announced a collaboration to establish interoperability between the Rosetta Resolver(R) system and the Ingenuity Pathways Analysis system. Researchers will be able to easily exchange data
Rosetta Biosoftware and Agendia to Deliver Diagnostic Utilities; Agendia Licenses the Rosetta Resolver System
CCNMatthews Newswire ; SEATTLE and AMSTERDAM, The NetherlandsCCNMatthews - Oct 3, 2005) - Rosetta Biosoftware and Agendia today announced that the two organizations will work together to deliver novel diagnostics tools that will be made available in the Rosetta Resolver(R) system for gene expression data analysis. In
Rosetta Biosoftware Licenses the Rosetta Resolver Gene Expression Analysis System to FoxHollow Technologies
CCNMatthews Newswire ; SEATTLE and REDWOOD CITY, CalifCCNMatthews - Mar 13, 2006) - Rosetta Biosoftware announced today that FoxHollow Technologies has licensed the Rosetta Resolver(R) system for research on cardiovascular disease. FoxHollow Technologies developed and markets the SilverHawk(TM) Plaque Excision System, an
Almac Diagnostics Licenses the Rosetta Resolver Expression Data Analysis System
CCNMatthews Newswire ; CRAIGAVON, Northern Ireland and SEATTLECCNMatthews - Mar 29, 2006) - Almac Diagnostics and Rosetta Biosoftware announced today that Almac Diagnostics (formerly ArraDx Ltd) licensed the Rosetta Resolver(R) system for use in the development of novel microarray- based approaches for diagnosing cancer
Rosetta Biosoftware Introduces the Rosetta Resolver Gene Expression Data Analysis System Version 6.0
CCNMatthews Newswire ; SEATTLECCNMatthews - Feb 27, 2006) - Rosetta Biosoftware today introduced the Rosetta Resolver(R) gene expression data analysis system 6.0, with capabilities to support toxicogenomics research. The new version of the Resolver system will be presented at the Society of Toxicology annual meeting and
Lakeland Regional Cancer Center Licenses the Rosetta Resolver Expression Data Analysis System
CCNMatthews Newswire ; LAKELAND, Fla., and SEATTLECCNMatthews - Feb 6, 2006) - Lakeland Regional Cancer Center and Rosetta Biosoftware announced today that Lakeland Regional Cancer Center licensed the Rosetta Resolver(R) system to investigate the clinical value of microarrays for assisting in cancer staging, the process